Clinical Trials Directory

Trials / Sponsors / Sirnaomics

Sirnaomics

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
UnknownSafety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrop
Hypertrophic Scar
Phase 1 / Phase 22023-06-01
UnknownSingle Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
FXI
Phase 12023-05-16
CompletedStudy to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC
Facial isSCC
Phase 1 / Phase 22022-08-01
CompletedA Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty
Abdominal Obesity
Phase 12022-08-01
CompletedA Study of STP707 Administered by IV in Healthy Subjects
Healthy Subjects
Phase 12022-02-28
UnknownPh. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Solid Tumor
Phase 12021-11-01
CompletedA Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
Squamous Cell Carcinoma in Situ
Phase 22021-05-18
CompletedA Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
Keloid
Phase 22021-04-29
CompletedSafety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unr
Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma
Phase 12021-03-01
CompletedOpen Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carc
Basal Cell Carcinoma
Phase 22020-12-28
CompletedOpen Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC
Bowen's Disease, Cutaneous Squamous Cell Carcinoma in Situ
Phase 1 / Phase 22019-03-21
CompletedA Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophi
Hypertrophic Scar
Phase 1 / Phase 22017-01-01